These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 25061867)

  • 1. Patient outcomes and surgical complications in coccidioidomycosis-related hydrocephalus: an institutional review.
    Hardesty DA; Ramey W; Afrasiabi M; Beck B; Gonzalez O; Moran A; Nakaji P
    J Neurosurg; 2014 Oct; 121(4):785-9. PubMed ID: 25061867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shunt Treatment for Coccidioidomycosis-Related Hydrocephalus: A Single-Center Series.
    Morshed RA; Lee AT; Egladyous A; Avalos LN; Aghi MK; Theodosopoulos PV; McDermott MW; Hervey-Jumper SL
    World Neurosurg; 2020 Jun; 138():e883-e891. PubMed ID: 32247798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morbidity of ventricular cerebrospinal fluid shunt surgery in adults: an 8-year study.
    Korinek AM; Fulla-Oller L; Boch AL; Golmard JL; Hadiji B; Puybasset L
    Neurosurgery; 2011 Apr; 68(4):985-94; discussion 994-5. PubMed ID: 21221037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Shunt Outcomes for Nonbacterial Infection Hydrocephalus with Common Hydrocephalus Etiologies: A Retrospective Case-Control Study.
    Cummins DD; Morshed RA; Goldschmidt E; Kuo YH
    World Neurosurg; 2022 Aug; 164():e582-e589. PubMed ID: 35552038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do antibiotic-impregnated shunts in hydrocephalus therapy reduce the risk of infection? An observational study in 258 patients.
    Ritz R; Roser F; Morgalla M; Dietz K; Tatagiba M; Will BE
    BMC Infect Dis; 2007 May; 7():38. PubMed ID: 17488498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revision rate of pediatric ventriculoperitoneal shunts after 15 years.
    Stone JJ; Walker CT; Jacobson M; Phillips V; Silberstein HJ
    J Neurosurg Pediatr; 2013 Jan; 11(1):15-9. PubMed ID: 23101557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prior CSF shunting increases the risk of endoscopic third ventriculostomy failure in the treatment of obstructive hydrocephalus in adults.
    Woodworth G; McGirt MJ; Thomas G; Williams MA; Rigamonti D
    Neurol Res; 2007 Jan; 29(1):27-31. PubMed ID: 17427271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gravity assisted vs. medium pressure valves for communicating hydrocephalus show similar valve-revision rates.
    Schatlo B; Hamed M; Grote A; Schramm J; Neuloh G
    Acta Neurochir (Wien); 2013 Oct; 155(10):1987-91. PubMed ID: 23989996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges in cerebrospinal fluid shunting in patients with glioblastoma.
    Hong B; Polemikos M; Heissler HE; Hartmann C; Nakamura M; Krauss JK
    Fluids Barriers CNS; 2018 Jun; 15(1):16. PubMed ID: 29860942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of antibiotic-impregnated shunt catheters in decreasing the incidence of shunt infection in the treatment of hydrocephalus.
    Sciubba DM; Stuart RM; McGirt MJ; Woodworth GF; Samdani A; Carson B; Jallo GI
    J Neurosurg; 2005 Aug; 103(2 Suppl):131-6. PubMed ID: 16370278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of programmable shunt valves vs standard valves for communicating hydrocephalus of adults: a retrospective analysis of 407 patients.
    Ringel F; Schramm J; Meyer B
    Surg Neurol; 2005 Jan; 63(1):36-41; discussion 41. PubMed ID: 15639519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes following cerebrospinal fluid shunting in high-grade glioma patients.
    Rinaldo L; Brown D; Lanzino G; Parney IF
    J Neurosurg; 2018 Oct; 129(4):984-996. PubMed ID: 29271709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rate of shunt revision as a function of age in patients with shunted hydrocephalus due to myelomeningocele.
    Dupepe EB; Hopson B; Johnston JM; Rozzelle CJ; Jerry Oakes W; Blount JP; Rocque BG
    Neurosurg Focus; 2016 Nov; 41(5):E6. PubMed ID: 27798984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ventriculosubgaleal shunts for posthemorrhagic hydrocephalus in premature infants.
    Willis BK; Kumar CR; Wylen EL; Nanda A
    Pediatr Neurosurg; 2005; 41(4):178-85. PubMed ID: 16088252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting shunt failure in children: should the global shunt revision rate be a quality measure?
    Rossi NB; Khan NR; Jones TL; Lepard J; McAbee JH; Klimo P
    J Neurosurg Pediatr; 2016 Mar; 17(3):249-59. PubMed ID: 26544083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost analysis of antibiotic-impregnated catheters in the treatment of hydrocephalus in adult patients.
    Farber SH; Parker SL; Adogwa O; Rigamonti D; McGirt MJ
    World Neurosurg; 2010; 74(4-5):528-31. PubMed ID: 21492607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Long-term results of hydrocephalus with myelomeningocele].
    Kojima N; Tamaki N; Matsumoto S
    No To Shinkei; 1990 Sep; 42(9):879-88. PubMed ID: 2245084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complications of endoscopic third ventriculostomy in previously shunted patients.
    Hader WJ; Walker RL; Myles ST; Hamilton M
    Neurosurgery; 2008 Jul; 63(1 Suppl 1):ONS168-74; discussion ONS174-5. PubMed ID: 18728596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Posthemorrhagic hydrocephalus and shunts: what are the predictors of multiple revision surgeries?
    Chittiboina P; Pasieka H; Sonig A; Bollam P; Notarianni C; Willis BK; Nanda A
    J Neurosurg Pediatr; 2013 Jan; 11(1):37-42. PubMed ID: 23101558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seven years of clinical experience with the programmable Codman Hakim valve: a retrospective study of 583 patients.
    Zemack G; Romner B
    J Neurosurg; 2000 Jun; 92(6):941-8. PubMed ID: 10839253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.